A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
Condition: Type 2 Diabetes Mellitus Intervention: Drug: Insulin Glargine Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | India Health | Insulin | Lantus | Research | Study